Text Image: UM Medical School: Graduate Program in Immunology
Text Image: Faculty

Weiping Zou, M.D., Ph.D.
Charles B. de Nancrede Professor
of Surgery, Immunology, and Biology
Co-Director, Tumor Immunology and Host Response Program
Director, Translational Research

Co-Director, Immune Monitoring Core

wzou@umich.edu

 

Research interests:
Tumor immunity, Immune suppression and immune vaccination


Current Research Activity:

B7 family members and dendritic cells in tumors, regulatory T cells in tumors, immune cell trafficking in tumors, novel animal models for cancer, mechanistic interaction between tumor, host immune cells and stems cells, the translational aspects of novel immune-based interventions in patients with cancer.


Recent Publications:

Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E, Vatan L, et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity 2014;40:772-784.

Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, et al. Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity 2013;39:611-621.


Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, Nunez G, Zou W. Interleukin (IL)-10 ablation promotes tumor development, growth and metastasis. Cancer Res 2011.


Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, Moyer J, et al. Human TH17 Cells Are Long-Lived Effector Memory Cells. Sci Transl Med 2011;3:104ra100.


Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, Huang E, et al. IL-17(+) regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol 2011;186:4388-4395.

Wilke CM, Wang L, Wei S, Kryczek I, Huang E, Kao J, Lin Y, et al. Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. J Transl Med 2011;9:217.


Zou W,
Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010;10:248-256.

Zou W,
Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008;8:467-477.

Zou W
, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nature Review (Immunology), 2008, 8:467-477.


Shuang Wei, Ilona Kryczek, Robert P. Edwards, Linhua Vant, Wojciech Szeliga, Mousumi Banerjee, Marilyn Cost, Pui Cheng, Alfred Chang, Bruce Redman, Ronald B. Herberman, Weiping Zou. Interleukin 2 administration alters the CD4+FOXP3+ T cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res . 2007 Aug 1;67(15):7487-94.


Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, et al. Interleukin-2 Administration Alters the CD4+FOXP3+ T-Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma. Cancer Res 2007;67:7487-7494.

Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood. 2006 Jul 15;108(2):426-31.

Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H, Chen L, Zou W. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol. 2006 Jul 1;177(1):40-4

Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med. 2006 Apr 17;203(4):871-81.

Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006 Apr;6(4):295-307. Review.

Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 2005 Jun 15;65(12):5020-6.

Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005 Apr;5(4):263-74. Review.

Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, Zou W. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 2005 Jan 15;65(2):465-72

Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 2004 Nov 15;64(22):8451-5.

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004 Sep;10(9):942-9.

Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Chen L, Zou W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med. 2003 May;9(5):562-7.

Zou W , Mache Lon V , Coulomb-L'Hermin A , Borvak J , Nome F , Isaeva T , Wei S , Krzysiek R , Durand-Gasselin I , Gordon A , Pustilnik T , Curiel DT , Galanaud P , Capron F , Emilie D , Curiel TJ . Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med. 2001 Dec;7(12):1339-46.

 

 


About Us
| Research Opportunities | Faculty | Graduate Students | Admissions | Coursework | Immunology Seminars | Life in A2
UM Gateway | UM Medical School | Program in Biological Sciences | UM Health System
Web Design by BMC Media

Copyright © 2002 The Regents of the University of Michigan